The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS)
Authors:
- K. S. Astrakova (Benimetskaya)K(K. S. Astrakova (Benimetskaya)
- I. L. MikheenkoIMI. L. Mikheenko
- A. E. UranovAUA. E. Uranov
- A. A. GartungAGA. A. Gartung
- E. A. KovalevEKE. A. Kovalev
- A. A. SpiridonovASA. A. Spiridonov
- I. I. ShestovaISI. I. Shestova
- I. L. StrokolskayaISI. L. Strokolskaya
- M. A. MeshkovaMMM. A. Meshkova
- L. I. EsevLEL. I. Esev
- А. V. ReznikАRА. V. Reznik
- V. А. PetrakovskaiaVPV. А. Petrakovskaia
Open Access
- 28 November 2024
- journal article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (6) , 625-636
Abstract
Aim. To assess the effectiveness of clinical decision support system (CDSS) implementation strategy in increasing the frequency of low-density lipoprotein cholesterol (LDL-С) monitoring in patients hospitalized for acute cardiovascular events (CVEs), in patients with coronary artery disease (CAD) or dyslipidemia.Material and methods. A non-interventional, retrospective, multicentre study assessing the impact of a CDSS with automatic electronic medical record (EMR) data processing on adherence to guidelines in patients at risk of cardiovascular diseases (SuccESS) was performed. The study included two cohorts of patients from healthcare facilities in three regions of Russia. The main cohort consisted of patients hospitalized for acute CVEs, with 12,227 patients included in the first follow-up period and 11,364 patients included in the second follow-up period. The additional cohort consisted of patients with stable CAD or dyslipidemia, with 54 469 patients included in the first follow-up period and 94,616 patients included in the second follow-up period. The study assessed follow-up findings in real-world clinical practice before and after the CDSS was implemented (first and second follow-up periods, respectively). The median duration of follow-up in the main cohort was >158 days in the first follow-up period and >227 days in the second follow-up period.Results. In the second follow-up period the proportion of patients with available data on LDL-C control in the EMR increased from 12.3% to 18.8% (here and further — relative change: +52.3%, pConclusion. The study findings demonstrate the positive impact of CDSS on several parameters that determine the quality and organization of medical care. The CDSS can be used to improve clinical and managerial decisions.Keywords
This publication has 20 references indexed in Scilit:
- Effect of clinical decision support for severe hypercholesterolemia on low-density lipoprotein cholesterol levelsnpj Digital Medicine, 2024
- Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyThe Lancet Regional Health - Europe, 2023
- Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patientsInternational Journal of Cardiology, 2021
- Retrospective analysis of clinical decision support system use in patients with hypertension and atrial fibrillation (INTELLECT)Russian Journal of Cardiology, 2021
- Assessment of Variation in Electronic Health Record Capabilities and Reported Clinical Quality Performance in Ambulatory Care Clinics, 2014-2017JAMA Network Open, 2021
- EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI studyEuropean Journal of Preventive Cardiology, 2020
- Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular DiseaseCirculation, 2018
- Associations between healthcare quality and use of electronic health record functions in ambulatory careJournal of the American Medical Informatics Association, 2015
- Low Density Lipoprotein Cholesterol and Coronary Heart Disease – Lower is BetterEuropean Cardiology Review, 2005
- Primary Prevention of Coronary Heart DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2000